Fig. 1 · Structure
Documents & Downloads
GSK8573
Inactive Control Compound
GSK8573 is an inactive control compound with a specific binding affinity to BRD9, exhibiting a Kd value of 1.04 μM. While it acts as an acetyl-lysine competitive inhibitor, GSK8573 is not active against BAZ2A/B or other bromodomain family members. This compound serves as a structurally related negative control in biological experiments, allowing researchers to validate findings in studies involving bromodomain interactions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1693766-04-9 |
| Applications | Inactive Control Compound |
| Formula | C20H21NO3 |
| Molecular Weight | 323.39 |
| SMILES | CC(C1=CC(C2=CC=CC(OC)=C2)=C3C=C(OCCC)C=CN13)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.